The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament
Authors:
- Jorge MonserratJorge Monserrat
- Cristina BohórquezCBCristina Bohórquez
- Ana María Gómez LahozALAna María Gómez Lahoz
- Atusa MovasatAMAtusa Movasat
- Ana PérezAPAna Pérez
- Lucía RuízLRLucía Ruíz
- David DíazDDDavid Díaz
- Luis CharaLCLuis Chara
- Ana Isabel SánchezASAna Isabel Sánchez
- Fernando AlbarránFAFernando Albarrán
- Ignacio SanzISIgnacio Sanz
- Melchor Álvarez-MonMelchor Álvarez-Mon
Open Access
Abstract
Patients with long-term, treated, rheumatoid arthritis (RA) show abnormalities in their circulating CD4+ T-lymphocytes, but whether this occurs in recently diagnosed naïve patients to disease-modifying drugs (DMARDs) is under discussion. These patients show heterogeneous clinical response to methotrexate (MTX) treatment. We have examined the count of circulating CD4+ T-lymphocytes, and their naïve (TN), central memory (TCM), effector memory (TEM) and effector (TE) subsets, CD28 expression and Vβ TCR repertoire distribution by polychromatic flow cytometry in a population of 68 DMARD-naïve recently diagnosed RA patients, before and after 3 and 6 months of MTX treatment. At pre-treatment baseline, patients showed an expansion of the counts of CD4+ TN, TEM, TE and TCM lymphocyte subsets, and of total CD4+CD28− cells and of the TE subset with a different pattern of numbers in MTX responder and non-responders. The expansion of CD4+TEM lymphocytes showed a predictive value of MTX non-response. MTX treatment was associated to different modifications in the counts of the CD4+ subsets and of the Vβ TCR repertoire family distribution and in the level of CD28 expression in responders and non-responders. In conclusion, the disturbance of CD4+ lymphocytes is already found in DMARD-naïve RA patients with different patterns of alterations in MTX responders and non-responders.Keywords
Funding Information
- Fondo de Investigación de la Seguridad Social, Instituto de Salud Carlos III (PI18/01726)
- Actividades de I+D de la Comunidad de Madrid en Biomedicina (B2017/BMD-3804)
This publication has 73 references indexed in Scilit:
- When aging reaches CD4+ T-cells: phenotypic and functional changesFrontiers in Immunology, 2013
- Standardizing immunophenotyping for the Human Immunology ProjectNature Reviews Immunology, 2012
- Older age of rheumatoid arthritis onset is associated with higher activation status of peripheral blood CD4+ T cells and disease activityClinical and Experimental Immunology, 2010
- Immune Aging and Rheumatoid ArthritisRheumatic Disease Clinics of North America, 2010
- CD28− T cells: their role in the age-associated decline of immune functionTrends in Immunology, 2009
- Aging and T-cell diversity☆Experimental Gerontology, 2007
- Skewed T-cell receptor BV14 and BV16 expression and shared CDR3 sequence and common sequence motifs in synovial T cells of rheumatoid arthritisGenes & Immunity, 2005
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteriaArthritis & Rheumatism, 1996
- T-cell antigen receptor genes and T-cell recognitionNature, 1988